-
Study aim
-
Determining the effect of oral syrup containing Pistacia atlantica oleoresin in improving subacute and chronic cough symptoms
-
Design
-
The study is conducted as a randomized clinical trial with a control group, with two parallel groups and in a three-way blind (patient, doctor, data analyst) and patients are randomly divided into groups. Twenty-four non-smoking outpatients with chronic cough (duration of cough between 8 and 100 months) of any origin referred to Shahid Rahimi Hospital clinic from the beginning of 2014 to 2014.
-
Settings and conduct
-
Permuted block randomization so that first all 4 blocks containing two codes A and B are prepared (6 blocks) then random blocks are selected by placement using a table of random numbers. These blocks form a sample-sized sequence of A and B codes, each of which is randomly assigned to one of the groups. The list of relevant codes will remain confidential until the end of the project. The place of study is the doctor's office in Khorramabad.
-
Participants/Inclusion and exclusion criteria
-
Entry criteria: subacute (3 to 8 weeks) and chronic (more than 8 weeks) cough, age over 18 years
Exclusion criteria: use of other antitussive drugs, opioids, sedatives, antihistamines, antibiotics, bronchodilators, history of asthma, history of chronic bronchitis, pneumonia, lung abscess or pulmonary tuberculosis, smokers.
-
Intervention groups
-
Groups receiving three doses of syrup containing Pistacia atlantica oleoresin
-
Main outcome variables
-
The number of cough attacks per day and the number of coughs per attack
Checking the quality of cough. In each examination, the level of recovery is evaluated as complete recovery (complete cessation of cough), partial recovery (the patient expresses satisfaction with the reduction of cough or the duration of cough is halved), no recovery (the medicine does not cause any change in the severity of cough).